36 results
8-K
EX-10.1
LEXX
Lexaria Bioscience Corp
14 Jul 14
Municipal Approval for Lexaria-Enertopia Joint Venture in Burlington, Ontario
12:00am
-lois.justice.gc.ca/eng/regulations/SOR-2013-119/. The Consultant will establish policies and procedures that align with the Company’s overall goals … financial goals are achieved. The Consultant will be tasked to find ways to reduce operational costs and increase revenues. The Consultant will plan
S-8
EX-4.1
LEXX
Lexaria Bioscience Corp
18 Jan 24
Registration of securities for employees
2:38pm
the achievement of Company-wide, business unit, or individual goals (including, but not limited to, continued employment or service), or any other basis determined … and Restricted Stock Units will lapse, and, with respect to Awards with performance-based vesting, all performance goals or other vesting criteria
S-8
EX-4.1
LEXX
Lexaria Bioscience Corp
17 May 19
Registration of securities for employees
4:57pm
. The Administrator may set vesting criteria based upon the achievement of Company-wide, business unit, or individual goals (including, but not limited … goals or other vesting criteria will be deemed achieved at one hundred percent (100%) of target levels and all other terms and conditions met. In addition
8-K
LEXX
Lexaria Bioscience Corp
11 Apr 19
Departure of Directors or Certain Officers
12:00am
with the security of having its key personnel committed to the Lexaria Group’s goals for a three year term. The combined compensation payable or issuable
8-K
8enjfyyr dusk3s7p7r
2 Sep 22
Departure of Directors or Certain Officers
1:56pm
8-K
EX-99.1
dptru9ui6m5j5pb0utn
11 Apr 19
Departure of Directors or Certain Officers
12:00am
8-K
zrwv1w
4 Jan 22
Departure of Directors or Certain Officers
3:46pm
8-K
EX-99.2
z5p3b55kg
11 Jul 19
Lexaria Bioscience Enters CBD Beverage License Agreement with Nic’s Beverages
12:45pm
8-K
EX-99.1
h4e9ol7
24 Feb 15
Regulation FD Disclosure
12:00am
8-K
EX-99.2
wnmc6
8 Sep 21
Lexaria’s Human Clinical Study Delivers Effective and Safe Blood Pressure Reduction Results over 24-hour Ambulatory Period
4:46pm
8-K
EX-99.1
htkmt3q7
27 Jan 22
Regulation FD Disclosure
2:04pm
8-K
EX-10.1
4sqg8lkk
24 Feb 15
Regulation FD Disclosure
12:00am
8-K
EX-99.1
0ck0 v15i363d
9 Jan 20
Lexaria Bioscience CEO Discusses Strategic Outlook
3:43pm
8-K
EX-99.1
wp18 pbhpvtbln1wl
24 Jan 24
Regulation FD Disclosure
2:12pm
10QSB
9wav2bk
12 Sep 06
Quarterly report (small business)
12:00am